Key statistics dashboard for Zimmer Biomet Holdings, Inc. (ZBH). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific.
Stock Data
| Price | $88.29 |
| Market Cap | $17.1B |
| Beta | 0.61 |
| Exchange | NYSE |
| Country | US |
Valuation Multiples
| P/E Ratio | 21.38 |
| Price / Book | 1.34 |
| P/S | 2.01 |
| P/FCF | 9.33 |
| Dividend Yield | 1.09% |
Profitability
| Gross Margin | 69.87% |
| EBIT Margin | 14.44% |
| EBITDA Margin | 23.02% |
| Operating Margin | 15.73% |
| Net Margin | 9.48% |
Financial Health
| Current Ratio | 1.69 |
| Quick Ratio | 1.69 |
| Cash Ratio | 0.14 |
| Debt / Equity | 0.59 |
| Debt / Assets | 32.81% |
| Interest Coverage | 4.63 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 2.42 |
Per-Share Data
| Revenue per share | 44.27 |
| Book Value per share | 65.73 |
| Cash per share | 2.13 |
| FCF per share | 9.52 |
| Tangible Book Value per share | -9.10 |
| Dividend per share | 0.96 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 17 |
| Hold | 22 |
| Sell | 3 |
| Strong Sell | 0 |
| Total analysts | 42 |
| Avg rating (1-5) | 0.33 |
Related companies: DGX · DXCM · ILMN · INCY · LH · SNN · STE
Explore sector: Healthcare · Medical - Devices
More sections of ZBH: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks